BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 33407478)

  • 1. Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and focal adhesion formation.
    Zhao HF; Wu CP; Zhou XM; Diao PY; Xu YW; Liu J; Wang J; Huang XJ; Liu WL; Chen ZP; Huang GD; Li WP
    Cancer Cell Int; 2021 Jan; 21(1):24. PubMed ID: 33407478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition.
    Zhao HF; Wang J; Jiang HR; Chen ZP; To SS
    J Exp Clin Cancer Res; 2016 May; 35():78. PubMed ID: 27176481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multi-targeted Natural Flavonoid Myricetin Suppresses Lamellipodia and Focal Adhesions Formation and Impedes Glioblastoma Cell Invasiveness and Abnormal Motility.
    Zhao HF; Wang G; Wu CP; Zhou XM; Wang J; Chen ZP; To ST; Li WP
    CNS Neurol Disord Drug Targets; 2018; 17(7):557-567. PubMed ID: 29886836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction to: Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and focal adhesion formation.
    Zhao HF; Wu CP; Zhou XM; Diao PY; Xu YW; Liu J; Wang J; Huang XJ; Liu WL; Chen ZP; Huang GD; Li WP
    Cancer Cell Int; 2021 Jul; 21(1):403. PubMed ID: 34321007
    [No Abstract]   [Full Text] [Related]  

  • 5. PI3Kβ inhibitor AZD6482 exerts antiproliferative activity and induces apoptosis in human glioblastoma cells.
    Xu PF; Yang JA; Liu JH; Yang X; Liao JM; Yuan FE; Liu BH; Chen QX
    Oncol Rep; 2019 Jan; 41(1):125-132. PubMed ID: 30542720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR Signals through a DOCK180-MLK3 Axis to Drive Glioblastoma Cell Invasion.
    Misek SA; Chen J; Schroeder L; Rattanasinchai C; Sample A; Sarkaria JN; Gallo KA
    Mol Cancer Res; 2017 Aug; 15(8):1085-1095. PubMed ID: 28487380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLK3 regulates paxillin phosphorylation in chemokine-mediated breast cancer cell migration and invasion to drive metastasis.
    Chen J; Gallo KA
    Cancer Res; 2012 Aug; 72(16):4130-40. PubMed ID: 22700880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIK3CB/p110β is a selective survival factor for glioblastoma.
    Pridham KJ; Le L; Guo S; Varghese RT; Algino S; Liang Y; Fajardin R; Rodgers CM; Simonds GR; Kelly DF; Sheng Z
    Neuro Oncol; 2018 Mar; 20(4):494-505. PubMed ID: 29016844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Throughput Screening Identifies Mixed-Lineage Kinase 3 as a Key Host Regulatory Factor in Zika Virus Infection.
    Xu H; Cheng M; Chi X; Liu X; Zhou J; Lin T; Yang W
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31270223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MLK3 Is Associated With Poor Prognosis in Patients With Glioblastomas and Actin Cytoskeleton Remodeling in Glioblastoma Cells.
    Zhu Y; Sun JM; Sun ZC; Chen FJ; Wu YP; Hou XY
    Front Oncol; 2020; 10():600762. PubMed ID: 33692940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
    Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
    Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma models.
    von Achenbach C; Weller M; Kaulich K; Gramatzki D; Zacher A; Fabbro D; Reifenberger G; Szabó E
    J Neurochem; 2020 May; 153(4):510-524. PubMed ID: 31618458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glycolytic metabolism in glioblastoma cells by Pt3glc combinated with PI3K inhibitor via SIRT3-mediated mitochondrial and PI3K/Akt-MAPK pathway.
    Wang G; Fu XL; Wang JJ; Guan R; Sun Y; Tony To SS
    J Cell Physiol; 2019 May; 234(5):5888-5903. PubMed ID: 29336479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet PI3Kβ and GSK3 regulate thrombus stability at a high shear rate.
    Laurent PA; Séverin S; Hechler B; Vanhaesebroeck B; Payrastre B; Gratacap MP
    Blood; 2015 Jan; 125(5):881-8. PubMed ID: 25398937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of Akt and FAK phosphorylation reduces invasion of glioblastoma cells by impairment of MT1-MMP shuttling to lamellipodia and downregulates MMPs expression.
    Kwiatkowska A; Kijewska M; Lipko M; Hibner U; Kaminska B
    Biochim Biophys Acta; 2011 May; 1813(5):655-67. PubMed ID: 21276823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connective tissue growth factor induces collagen I expression in human lung fibroblasts through the Rac1/MLK3/JNK/AP-1 pathway.
    Lin CH; Yu MC; Tung WH; Chen TT; Yu CC; Weng CM; Tsai YJ; Bai KJ; Hong CY; Chien MH; Chen BC
    Biochim Biophys Acta; 2013 Dec; 1833(12):2823-2833. PubMed ID: 23906792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity to Support Breast Cancer Cell Survival.
    Das S; Sondarva G; Viswakarma N; Nair RS; Osipo C; Tzivion G; Rana B; Rana A
    J Biol Chem; 2015 Aug; 290(35):21705-12. PubMed ID: 26152725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant Inhibition of PI3Kβ and BRAF or MEK in PTEN-Deficient/BRAF-Mutant Melanoma Treatment: Preclinical Assessment of SAR260301 Oral PI3Kβ-Selective Inhibitor.
    Bonnevaux H; Lemaitre O; Vincent L; Levit MN; Windenberger F; Halley F; Delorme C; Lengauer C; Garcia-Echeverria C; Virone-Oddos A
    Mol Cancer Ther; 2016 Jul; 15(7):1460-71. PubMed ID: 27196754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells.
    Schroyer AL; Stimes NW; Abi Saab WF; Chadee DN
    Oncogene; 2018 Feb; 37(8):1031-1040. PubMed ID: 29084209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.